Antares Pharma, 100 Princeton South Corporate Center, Suite 300, Ewing 08628. 609-359-3020. Robert F. Apple, president and CEO. www.antarespharma.com.
A U.S. District Court judge has dismissed a class action lawsuit filed against Ewing-based pharmaceutical company Antares.
The lawsuit brought by lead plaintiff Serghei Lungu alleged that Antares had purposely misled investors about the risks associated with its testosterone-enhancing drug QuickShot Testosterone, marketed as Xyosted.
The lawsuit concerned the period between December, 2016, when the drug was submitted to the Food & Drug Administration for approval, and October, 2017, when Antares announced that the FDA had found deficiencies in the application. The drug was ultimately approved with a required warning label about the risk of side effects including depression, suicide, and high blood pressure.
Lungu made the case that statements made by Antares executives during this period, for example “QST was found to be safe” and “QST showed ‘positive … safety data,’” were made to intentionally mislead investors despite known safety issues.
In dismissing the suit, however, the judge ruled that these were “vague and general statements of optimism” that a reasonable investor would not use to make decisions.
“Because plaintiff fails to plead facts that show defendants did not honestly believe the studies produced positive safety data and lacked a reasonable basis for this opinion … Plaintiff fails to show that this statement is actionable,” the judge said.
TerraCycle, 121 New York Avenue, Trenton 08638. 609-393-4252. Tom Szaky, CEO. www.terracycle.com.
A Los Angeles-based coffee producer has partnered with Trenton-based Terracycle on a recycling program for its single-use coffee pods.
The national program allows consumers of F. Gavina & Sons’ Don Francisco’s Coffee and Cafe La Llave Espresso to mail used coffee pods to TerraCycle using any box and a prepaid shipping label provided by TerraCycle. The remaining coffee grounds are separated and sent to an industrial composing facility, while the plastic pods are melted down to be recycled into other products.
“At TerraCycle, we understand American’s love affair with a great cup of coffee — we share the sentiment,” TerraCycle Founder and CEO Tom Szaky said in a statement. “But through the Coffee Pod Recycling Program, coffee connoisseurs can enjoy their favorite pick-me-up, easily reduce waste, all without sacrificing the enjoyment of their favorite brew.”
TerraCycle has announced a similar partnership with Living Proof, a manufacturer of hair care products, to recycle aerosol cans and other hair product packaging.
“We are pleased to count Living Proof among a select group of luxury hair care brands that offer consumer-facing recycling programs that actively address this large category of waste,” Szaky said in a statement.
To register for recycling programs visit www.terracycle.com.
Imbue Creative, 71 North Main Street, Lambertville 08530. Michael Piperno, founder and president. www.imbuecreative.com.
Imbue Creative, a branding and marketing agency based in Lambertville, has announced that Erin Klebaur will succeed the agency’s founder, Michael Piperno, as its new president, effective May 15.
Klebaur most recently served as Imbue’s director of client success. In a statement she said, “I’ve been extremely fortunate to work with a great team at Imbue, and I am looking forward to this next opportunity to build on a remarkably solid foundation.
“In the months ahead, the team and I will look to expand our breadth of services and continue to add to the success stories and client victories Imbue Creative has become so well known for.”
Piperno, who founded the agency in 2004, said “I am confident Erin will take Imbue to new heights, boosting the firm’s reputation for creativity and excellence.”
Prior to her time at Imbue, Klebaur served as the director of client services for a full-service marketing agency based in Princeton for 14 years. She earned her bachelor’s in communications with a minor in marketing and advertising from Rider University. She lives in Raritan Township with her husband, Pete, and twin sons.
Taft Communications, 2000 Lenox Drive, Suite 200, Lawrenceville 08648. 609-683-0700. Ted Deutsch, president. www.taftcommunications.com.
Lenox Drive-based consultancy Taft Communications has appointed Aaron Brown as creative director. Brown was most recently a creative director at PureRED, an advertising agency based on College Road East. In his career he has created advertising campaigns for notable brands including Arm & Hammer, Allegra, JetBlue, and GoDaddy.com. He holds a bachelor’s degree in journalism from Northwestern and a master’s in writing for screen and television from the University of Southern California.
“Aaron is a great catch for Taft, allowing us to up our game on the creative we deliver for clients,” said Taft president Ted Deutsch. “He not only brings diverse brand experience to our team, but he shares the firm’s passion for purpose-driven communications that make a real impact on stakeholders.”
New Jersey Future, 16 West Lafayette Street, Trenton 08608. 609-393-0008. Peter Kasabach, executive director. www.njfuture.org
The Trenton-based nonprofit New Jersey Future has announced the appointment of four new trustee.
They are Laureen Boles, founder and president of Philadelphia-based E4Progress and former executive director of the New Jersey Environmental Justice Alliance; Christopher Brown, director of community development for the City of Hoboken, who oversees the city’s redevelopment and master planning, zoning office, land use boards, affordable housing, Community Development Block Grant Program, and other community development initiatives;
Kenneth Esser, senior vice president and chief of staff of corporate services, governance, and government relations at Hackensack Meridian Health, past PSE&G business development manager involved with reducing greenhouse gas emissions, and chief energy advisor to Governor Jon Corzine; and Todd Gomez, North Region market executive for Community Development Banking at Bank of America and past chief financial officer for the Chicago Housing Authority.
New Jersey Future is a nonprofit, nonpartisan organization that promotes sensible growth, redevelopment and infrastructure investments to foster vibrant cities and towns, protect natural lands and waterways, enhance transportation choices, provide access to safe, affordable and aging-friendly neighborhoods, and fuel a strong economy.
NJ Tech Council, PSEG Launch CleanTech Challenge
The New Jersey Tech Council, a nonprofit that supports innovators in business and technology, has partnered with the state’s largest utility to create the CleanTech Alliance.
The alliance, launched in April, is kicking off with a CleanTech Impact Challenge with a $50,000 cash prize. Startups with under $2 million in revenue that are working on innovative solutions to promote and create energy efficiency and energy equity are encouraged to apply. The application deadline is July 31, and the winner will be honored at the Propelify Innovation Festival in September.
NJ Tech Council, 96 Albany Street, New Brunswick 08901. 732-456-5700. Aaron Price, CEO. www.njtc.org.
Adare Pharmaceuticals, 1200 Lenox Drive, Suite 100, Lawrenceville 08648. 609-450-1312. John Fraher, CEO. www.adarepharma.com.
Lenox Drive-based Adare Pharmaceuticals has acquired Orbis Biotechnologies, a pharmaceutical technology company located in Kansas.
The acquisition enhances Adare’s pharmaceutical technology business, which includes products for global pharmaceutical, animal health, and over-the-counter products. Orbis’ proprietary technology, Precision Particle Fabrication, creates uniform particles for use in drugs taken orally, by injection, or through the ear.
“Orbis’s customized technologies are an excellent complement to our contract development and manufacturing organization (CDMO) business which is currently focused on oral dosage forms for pharmaceutical and OTC medicines,” said John Fraher, CEO of Adare Pharmaceuticals, in a statement. “In particular, their platforms create drug particles that can be dosed in oral liquid, injectable, and otic dosage forms. These will broaden our product development offerings and ultimately, advance the growth of our CDMO business, further strengthening our leadership in taste-masking and controlled-release technologies.”
The transaction closed on April 30 for an undisclosed amount. Orbis will maintain its operations in Kansas.
Princeton Medical Institute, 256 Bunn Drive, Suite 6, Princeton 08540. 609-921-3555. Jeffrey Apter, lead principal investigator. www.gminstitutes.com.
Princeton Medical Institute, a research organization that conducts clinical trials in psychiatry and neurology, has created a new division called Neuroscience Innovations. Sanjay Varma, a psychiatrist, has been appointed associate medical director and will oversee the new division.
The new division specializes in depression treatments including Ketamine therapy, Spravato therapy, transcranial magnetic stimulation (TMS), Zulpresso for postpartum depression, and new clinical trials including an ultra-rapidly acting medication and an upcoming Botox study.